BioCardia, Inc. BCDA announced that the FDA has approved its investigational new drug (“IND”) application to initiate a clinical study on its pre-clinical pipeline candidate, BCDA-04. The company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback